Development of a bioactive porous collagen/β‐tricalcium phosphate bone graft assisting rapid vascularization for bone tissue engineering applications. Issue 1 (26th September 2017)

• Record Type: Journal Article
• Authors: Baheiraei, Nafiseh; Nourani, Mohamma Reza; Mortazavi, Seyed Mohammad Javad; Movahedin, Mansoureh; Eyni, Hossein; Bagheri, Fatemeh; Norahan, Mohammad Hadi
• Is Part Of: Journal of biomedical materials research. Volume 106:Issue 1(2018)
• Page Start: 73
• Page End: 85
• Publication Date: 2017-09-26
• Subjects: angiogenesis -- bone substitute -- collagen -- β‐tricalcium phosphate -- tissue engineering; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.a.36207
• Languages: English
• ISSNs: 1549-3296

Abstract

Abstract: We developed collagen (COL) and collagen/beta tricalcium phosphate (COL/β‐TCP) scaffolds with a β‐TCP/collagen weight ratio of 4 by freeze‐drying. Mouse bone marrow‐derived mesenchymal stem cells (BMMSCs) were cultured on these scaffolds for 14 days. Samples were characterized by physicochemical analyses and their biological properties such as cell viability and alkaline phosphatase (ALP) activity was, also, examined. Additionally, the vascularization potential of the prepared scaffolds was tested subcutaneously in Wistar rats. We observed a microporous structure with large porosity (∼95–98%) and appropriate pore size (120–200 µm). The COL/β‐TCP scaffolds had a much higher compressive modulus (970 ± 1.20 KPa) than pure COL (0.8 ± 1.82 KPa). In vitro model of apatite formation was established by immersing the composite scaffold in simulated body fluid for 7 days. An ALP assay revealed that porous COL/β‐TCP can effectively activate the differentiation of BMMSCs into osteoblasts. The composite scaffolds also promoted vascularization with good integration with the surrounding tissue. Thus, introduction of β‐TCP powder into the porous collagen matrix effectively improved the mechanical and biological properties of the collagen scaffolds, making them potential bone substitutes for enhanced bone regeneration in orthopedic and dental applications. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 73–85, 2018.